Al-Razi Medical Company Statistics

Total Valuation

Al-Razi Medical Company has a market cap or net worth of SAR 82.08 million. The enterprise value is 90.62 million.

Market Cap	82.08M
Enterprise Value	90.62M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Al-Razi Medical Company has 1.52 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.52M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	66.77%
Owned by Institutions (%)	n/a
Float	505,153

Valuation Ratios

The trailing PE ratio is 914.27.

PE Ratio	914.27
Forward PE	n/a
PS Ratio	1.32
PB Ratio	3.67
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.48, with an EV/FCF ratio of -1,031.83.

EV / Earnings	1,009.35
EV / Sales	1.46
EV / EBITDA	20.48
EV / EBIT	148.47
EV / FCF	-1,031.83

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.41.

Current Ratio	1.77
Quick Ratio	0.14
Debt / Equity	0.41
Debt / EBITDA	2.09
Debt / FCF	-105.14
Interest Coverage	1.16

Financial Efficiency

Return on equity (ROE) is 0.40% and return on invested capital (ROIC) is 1.20%.

Return on Equity (ROE)	0.40%
Return on Assets (ROA)	0.84%
Return on Capital (ROIC)	1.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.36
Inventory Turnover	2.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.52%
50-Day Moving Average	48.58
200-Day Moving Average	48.84
Relative Strength Index (RSI)	52.33
Average Volume (20 Days)	3,182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Al-Razi Medical Company had revenue of SAR 61.99 million and earned 89,777 in profits. Earnings per share was 0.06.

Revenue	61.99M
Gross Profit	16.34M
Operating Income	610,340
Pretax Income	438,203
Net Income	89,777
EBITDA	2.14M
EBIT	610,340
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 696,816 in cash and 9.23 million in debt, giving a net cash position of -8.54 million or -5.62 per share.

Cash & Cash Equivalents	696,816
Total Debt	9.23M
Net Cash	-8.54M
Net Cash Per Share	-5.62
Equity (Book Value)	22.38M
Book Value Per Share	14.72
Working Capital	11.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.06 million and capital expenditures -6.15 million, giving a free cash flow of -87,821.

Operating Cash Flow	6.06M
Capital Expenditures	-6.15M
Free Cash Flow	-87,821
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is 26.35%, with operating and profit margins of 0.98% and 0.14%.

Gross Margin	26.35%
Operating Margin	0.98%
Pretax Margin	0.71%
Profit Margin	0.14%
EBITDA Margin	3.45%
EBIT Margin	0.98%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.78, which amounts to a dividend yield of 1.48%.

Dividend Per Share	0.78
Dividend Yield	1.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	666.99%
Buyback Yield	n/a
Shareholder Yield	1.48%
Earnings Yield	0.11%
FCF Yield	-0.11%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Al-Razi Medical Company has an Altman Z-Score of 4.04.

Altman Z-Score	4.04
Piotroski F-Score	n/a